英文别名 |
AST2818 mesylate;Alflutinib mesylate;AST2818 (mesylate);Q09ZKD19V0;N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)acrylamide methanesulfonate;Alflutinib mesylate (AST2818;Alflutinib (AST2818) mesylate;BCP30340;s6868;2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-5-((4-(1-meth;Firmonertinib mesylate;BS-15901;Ivesa;EX-A2864;Alflutinib (mesylate);UNII-Q09ZKD19V0;GLXC-25390;Alflutinib (AST2818 mesylate)?;FURMONERTINIB MESILATE [WHO-DD];FURMONERTINIB MESILATE;AST-2818 mesylate;Furmonertinib mesylate;C29H35F3N8O5S;AC-35567;CS-0067492;MFCD31746903;2130958-55-1;AKOS037648870;N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]-6-(2,2,2-trifluoroethoxy)pyridin-3-yl]prop-2-enamide;methanesulfonic acid;ALFLUTINIB MESILATE;Alflutinib methanesulfonate;Alflutinib mesylate;AST 2818 mesylate;AST-2818 mesylate;ASK120067 mesylate;HY-112870A;D81030;N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)prop-2-enamide; methanesulfonic acid |